Company Name: Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a gene editing company. The company is engaged in the development of therapeutics using CRISPR/Cas9 technology.
Ticker Symbol: NTLA (NASDAQ)
Company Website: www.intelliatx.com
Company Profile:
Social Media:
Intellia Therapeutics LinkedIn
Headquarters: Cambridge, Massachusetts